Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(3,5-Dichloropyridin-4-yl)piperazine → 6-tert-Butyl-2-[4-(3,5-dichloropyridin-4-yl)piperazin-1-yl]-1H-benzoimidazole
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(3,5-Dichloropyridin-4-yl)piperazine | HCID 2799984 | — |
| 반응물 | 6-tert-Butyl-2-chloro-1H-benzoimidazole | HCID 11586517 | — |
| 생성물 | 6-tert-Butyl-2-[4-(3,5-dichloropyridin-4-yl)piperazin-1-yl]-1H-benzoimidazole | HCID 57835077 | — |
반응 단계
The 6-tert-butyl-2-chloro-1H-benzoimidazole (209 mg, 1 mmol, Example 17b) and 1-(3,5-dichloropyridin-4-yl)piperazine (464 mg, 2 mmol, Maybridge) reacted under the conditions of Example 1d to give the title compound as a white amorphous solid. MS (ESI, pos. ion) m/z: 404 (M+1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07582761B2 |
| 출처 데이터셋 | uspto-grants-2009_09 |
| ORD ID | ord-bd8da0e3de11476497b87fa16811cafd |
| 출처 메모 | uspto-grants-2009_09 |